Skip to content
EntityQ3088229· pop 17· linked from 51 articles

rasburicase

Sign in to save

Also known as SR-29142, urate oxidase, uricase, elitek

Rasburicase, sold under the brand name Elitek in the US and Fasturtec in the EU, is a medication that helps to clear uric acid from the blood. It is a recombinant version of urate oxidase, an enzyme that metabolizes uric acid to allantoin. Urate oxidase is known to be present in many mammals but does not naturally occur in humans. Rasburicase is produced by a genetically modified Saccharomyces cerevisiae strain. The complementary DNA (cDNA) coding for rasburicase was cloned from a strain of Aspergillus flavus.

Chemical data

Drug data · ChEMBL

Max clinical phase
Approved
Molecule type
Enzyme
First approval
2001
Admin. routes
parenteral
Indications
Burkitts lymphoma, diffuse large B-cell lymphoma, leukemia, lymphoma

via ChEMBL · EBI

Wikidata facts

Has use
medication
Show 5 more facts
medical condition treated
hyperuricemia
defined daily dose
14
subject has role
enzyme activator
legal status (medicine)
boxed warning
has characteristic
biopharmaceutical
Sources (7)

via Wikidata · CC0

~5 min read

Encyclopedic overview

10 sections
Contents
  • Medical uses
  • Contraindication
  • Side effects
  • Pharmacology
  • Mechanism of Action
  • Pharmacodynamics
  • Pharmacokinetics
  • Society and culture
  • Economics
  • References

Rasburicase, sold under the brand name Elitek in the US and Fasturtec in the EU, is a medication that helps to clear uric acid from the blood. It is a recombinant version of urate oxidase, an enzyme that metabolizes uric acid to allantoin. Urate oxidase is known to be present in many mammals but does not naturally occur in humans. Rasburicase is produced by a genetically modified Saccharomyces cerevisiae strain. The complementary DNA (cDNA) coding for rasburicase was cloned from a strain of Aspergillus flavus.

Rasburicase () is a tetrameric protein with identical subunits. Each subunit is made up of a single 301 amino acid polypeptide chain with a molecular mass of about 34 kDa. The drug product is a sterile, white to off-white, lyophilized powder intended for intravenous administration following reconstitution with a diluent. Elitek (rasburicase) is supplied in 3 mL and 10 mL colorless, glass vials containing rasburicase at a concentration of 1.5 mg/mL after reconstitution.

Excerpted from Wikipedia’s “rasburicase” article, available under the CC BY-SA 4.0 licence.